May 19, 2017May 19, 2017

Resokine Protein Key to Regulating Inflammation and Fibrosis in Lung Disease, Study Reports

Results from preclinical studies showed that restoring the levels of a protein called Resokine has therapeutic potential for the treatment of severe, rare pulmonary diseases characterized by inflammation and fibrosis, ... Read more

November 12, 2015November 12, 2015

Novel Severe Lung Disease Drug Therapy Pushing Forward

Idiopathic Pulmonary Fibrosis, News

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and clinical development of innovative Physiocrine-based medicines for patients suffering from severe rare diseases, recently announced that it has designated ... Read more